Brazil Therapeutic Respiratory Devices Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Oxygen Concentrator, Nebulizer, Humidifier), By Technology (Electrostatic Filter, HEPA Filter), By Filter, By Country, And Segment Forecasts

Market Size & Trends

The Brazil therapeutic respiratory devices market size was estimated at USD 343.74 million in 2024 and is expected to grow at a CAGR of 6.5% from 2025 to 2030. Respiratory devices are mainly used to treat conditions such as asthma and COPD. The demand for these devices increases as the patient population continues to grow. In addition, the aging population plays a significant role, as older adults are more susceptible to COPD, driving the need for respiratory devices. According to the Brazilian Institute of Geography  and Statistics- IBGE estimates published in August 2024, between 2000 and 2023, the percentage of elderly individuals (60 years and older) in Brazil nearly doubled, increasing from 8.7% to 15.6%. By 2070, around 37.8% of the country's population is projected to be aged 60 and above.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Product types such as nebulizers and ventilators have many smaller to large-size competitors relative to other markets because these devices rely less on drug approvals, ultimately leading to supporting the market for further expansion. Market competitors continue to dominate through their strong relationships with physicians and the launch of new devices. For instance, according to an April 2022 news event from CAIRE Inc., the company launched two new products, namely, Companion 5 and NewLife Intensity 10 Stationary Concentrators, in Brazil in July after receiving the go-ahead from ANVISA, the Brazilian health regulatory agency.

Advancements in technology have significantly contributed to market growth. Innovations, such as portable oxygen concentrators and smart monitoring systems, have made respiratory care more efficient and user-friendly. For instance, introducing mobile-compatible devices and real-time monitoring improved patient outcomes and convenience. These technological advancements are driving the adoption of respiratory devices in both clinical and home settings, driving continued growth in the market.

The COVID-19 pandemic had a positive impact on the market to some extent. Non-essential healthcare services and procedures were postponed or canceled initially due to shelter-in-place orders. However, connected care businesses saw increased demand, which was advantageous for major industry players. For instance, Philips N.V. reported positive growth in its connected care businesses during the first half of 2020, including the ventilator portfolio. According to Philips N.V.'s 2020 annual report, despite the pandemic's overall effects on the company, it managed to grow comparable sales by 3% and produce a healthy cash flow of EUR 1.9 billion.

Market Concentration & Characteristics

The degree of innovation in Brazil is high, with advancements focused on improving device portability, efficiency, and patient comfort. Companies are integrating smart technologies into respiratory devices, such as remote monitoring and AI-based diagnostics. For instance, oxygen concentrators with advanced filtration systems and mobile compatibility are gaining popularity, catering to growing home healthcare needs.

The market's merger and acquisition activities are moderate, with companies focusing on strategic partnerships and acquisitions to broaden their product portfolios and expand market reach. M&A is important in growing technological advancements, enhancing distribution channels, and strengthening market positioning. This medium level of consolidation facilitates growth and ensures healthy competition within the industry.

To learn more about this report, Download Free Sample Report

Regulations significantly impact the market, ensuring safety and efficacy. The National Health Surveillance Agency (ANVISA) enforces strict standards for medical devices, including respiratory equipment. For instance, all oxygen concentrators and ventilators comply with ANVISA’s safety regulations before entering the industry. These regulations drive innovation while maintaining high safety standards, contributing to market stability and growth.

Regional expansion is a high driver in the industry, as companies focus on reaching underserved areas with rising healthcare needs. The growth of chronic respiratory disease cases in Brazil's urban and rural regions boosts demand for respiratory devices. Manufacturers target local markets with tailored solutions, increasing accessibility and supporting the country's healthcare infrastructure development.

Product Insights

The nebulizers segment held the largest revenue share of 24.79% in 2024 due to their effectiveness in delivering medication directly to the lungs for treating respiratory conditions like asthma and COPD. The growing prevalence of these conditions and increased awareness of respiratory health drive the demand for nebulizers. In addition, the rising geriatric population and improvements in nebulizer technology, such as portable and quieter models, contribute to market growth. The rise in respiratory diseases accelerated the adoption of nebulizers, solidifying their largest revenue market share.

Capnographs is anticipated to grow at the fastest CAGR of 10.4% for the forecast period due to its crucial role in monitoring patients' carbon dioxide levels during respiratory therapy. These devices help ensure proper ventilation and detect respiratory complications in real-time, which is vital for critical care. The rise in surgeries, intensive care admissions, and respiratory conditions such as sleep apnea has driven demand. In addition, the increasing focus on patient safety and monitoring in hospitals and home healthcare settings contributes to capnograph adoption. The ongoing development of advanced, user-friendly models accelerates the growth of this segment in Brazil.

Technology Insights

The electrostatic filtration segment dominated the market due to its efficiency in trapping airborne particles and pathogens. Electrostatic filters use charged particles to attract and capture dust, bacteria, and viruses, improving patient air quality. This technology is widely used in ventilators, oxygen concentrators, and humidifiers, enhancing device performance. The growing prevalence of respiratory diseases, increased hospitalizations, and increased awareness about infection control have driven demand for electrostatic filtration in therapeutic devices during the COVID-19 pandemic, driving market adoption.

HEPA filter held the second position in the market, as HEPA filters are used in therapeutic respiratory devices to remove and retain airborne particles. To meet CDC guidelines, therapeutic equipment must include HEPA filtration for effective air purification. The growing incidence of respiratory disorders and the modes of their transmission are key factors driving the demand for HEPA filters in these devices.

Filter Insights

The ventilator filter segment held the largest revenue market share due to the critical role these filters play in ensuring the safety and efficacy of mechanical ventilation. With the increasing prevalence of respiratory diseases and the demand for ventilators, especially in hospitals, the need for high-quality filters is rising. These filters prevent contaminants and pathogens from entering the patient's respiratory system, improving patient outcomes. The COVID-19 pandemic increased the need for ventilators, driving demand for reliable ventilator filters. This segment's growth is supported by healthcare regulations emphasizing air quality standards in critical care settings.

To learn more about this report, Download Free Sample Report

The humidifier filter is expected to grow at the fastest rate from 2025 to 2030 due to the increasing need for moisture regulation in respiratory treatments. Humidifiers prevent airway drying, reduce irritation, and promote better outcomes for patients with respiratory conditions such as COPD and asthma. The rise in home healthcare and long-term respiratory care drove demand for these filters, as they enhance comfort and device efficiency. In addition, growing awareness of the importance of maintaining optimal air quality in medical devices and healthcare settings has driven the adoption of high-performance humidifier filters across Brazil.

Key Brazil Therapeutic Respiratory Devices Company Insights

Several key players dominate the market through a range of advanced products, including oxygen concentrators, nebulizers, and ventilators. These companies focus on offering innovative, high-quality solutions tailored to meet the increasing demand for respiratory care driven by the aging population and the rising prevalence of chronic respiratory diseases.

Recent Developments

• In April 2022, CAIRE Inc ., a worldwide oxygen equipment manufacturer, is set to broaden its product range in Latin America this summer. The Companion 5 and NewLife Intensity 10 stationary oxygen concentrators were introduced in July following approval from the Brazilian Health Regulatory Agency (Anvisa).

• “During the past two years, the COVID-19 pandemic oxygen shortages throughout South America have underscored the need to expand CAIRE’s portfolio of equipment available to providers to serve patients prescribed oxygen as they are discharged from the hospital.”

Brazil Therapeutic Respiratory Devices Market Report Segmentation

This report forecasts volume & revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Brazil therapeutic respiratory devices market report based on product, technology, and filter:

• Product Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)

  • Nebulizers

    • Compressor-based

    • Piston-based hand-held

    • Ultrasonic

  • Humidifiers

    • Heated

    • Passover

    • Integrated

    • Built-in

    • Standalone

  • Oxygen Concentrators

    • Fixed

    • Portable

  • Positive Airway Pressure Devices

    • Continuous PAP

    • Auto-titrating PAP

    • Bi-level PAP

  • Ventilators

    • Adult

    • Neonatal

  • Gas Analyzers

  • Capnographs

• Technology Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)

  • Electrostatic Filtration

  • HEPA Filter Technology

  • Hollow Fiber Filtration

  • Microsphere Separation

• Filter Outlook (Volume, Unit: Revenue, USD Million, 2018 - 2030)

  • Nebulizer Filters

    • Inlet Filters

    • Replacement Filters

    • Cabinet Filters

  • Humidifier Filters

    • Wick Filters

    • Permanent Cleanable Filters

    • Mineral Absorption Pads

    • Demineralization Cartridges

  • PAP Device Filters

    • Ultra Fine Foam Inlet Filters

    • Polyester Non-Woven Fiber Filters

    • Acrylic & Polypropylene Fiber Filters

  • Oxygen Concentrator Filters

    • HEPA Filters

    • Cabinet Filters

    • Pre-Inlet Filters

    • Inlet Filters

    • Felt Intake Filters

    • Bacterial Filters

    • Hollow Membrane Filters

    • Micro Disk Filters

  • Ventilator Filters

    • Mechanical Filters

      • HEPA Filters

      • ULPA Filters

      • Activated Carbon Filters

    • Electrostatic Filters

      • Tribocharged Filters

      • Fibrillated Filters